Marshall Wace North America’s Revance Therapeutics, Inc. RVNC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2018
Q2
Sell
-49,645
Closed -$1.53M 1752
2018
Q1
$1.53M Buy
49,645
+26,385
+113% +$813K 0.01% 883
2017
Q4
$832K Buy
+23,260
New +$832K ﹤0.01% 1032